Product Name :
Olmesartan medoxomil-d6
Description:
Olmesartan medoxomil-d6 (CS 866-d6) is the deuterium labeled Olmesartan medoxomil. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM.
CAS:
1127298-67-2
Molecular Weight:
564.62
Formula:
C29H30N6O6
Chemical Name:
(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-[2-hydroxy(1,1,1,3,3,3-²H₆)propan-2-yl]-2-propyl-1-{[2′-(2H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate
Smiles :
[2H]C([2H])([2H])C(O)(C1N=C(CCC)N(CC2C=CC(=CC=2)C2=CC=CC=C2C2=NNN=N2)C=1C(=O)OCC1OC(=O)OC=1C)C([2H])([2H])[2H]
InChiKey:
UQGKUQLKSCSZGY-LIJFRPJRSA-N
InChi :
InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)/i3D3,4D3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Obinutuzumab} MedChemExpress|{Obinutuzumab} CD20|{Obinutuzumab} Technical Information|{Obinutuzumab} Data Sheet|{Obinutuzumab} manufacturer|{Obinutuzumab} Epigenetic Reader Domain}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Olmesartan medoxomil-d6 (CS 866-d6) is the deuterium labeled Olmesartan medoxomil. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM.|Product information|CAS Number: 1127298-67-2|Molecular Weight: 564.62|Formula: C29H30N6O6|Chemical Name: (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-[2-hydroxy(1,1,1,3,3,3-²H₆)propan-2-yl]-2-propyl-1-{[2′-(2H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate|Smiles: [2H]C([2H])([2H])C(O)(C1N=C(CCC)N(CC2C=CC(=CC=2)C2=CC=CC=C2C2=NNN=N2)C=1C(=O)OCC1OC(=O)OC=1C)C([2H])([2H])[2H]|InChiKey: UQGKUQLKSCSZGY-LIJFRPJRSA-N|InChi: InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)/i3D3,4D3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Vandetanib} MedChemExpress|{Vandetanib} Protein Tyrosine Kinase/RTK|{Vandetanib} Biological Activity|{Vandetanib} References|{Vandetanib} custom synthesis|{Vandetanib} Cancer} |Shelf Life: ≥12 months if stored properly.PMID:23514335 |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.|Products are for research use only. Not for human use.|
